Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage

Brain

Volumn 138, Issue 5, 2015, Pages 1327-1338

  Vos, Stephanie J B ^a   Verhey, Frans ^a   Frölich, Lutz ^b   Kornhuber, Johannes ^c   Wiltfang, Jens ^d   Maier, Wolfgang ^e   Peters, Oliver ^f   Rüther, Eckart ^g   Nobili, Flavio ^h   Morbelli, Silvia ⁱ   Frisoni, Giovanni B ^j,k   Drzezga, Alexander ^l   Didic, Mira ^m   Van Berckel, Bart N M ⁿ   Simmons, Andrew ^o   Soininen, Hilkka ^p   Kłoszewska, Iwona ^q   Mecocci, Patrizia ^r   Tsolaki, Magda ^s   Vellas, Bruno ^t   Lovestone, Simon ^u   Muscio, Cristina ^j,v,w   Herukka, Sanna Kaisa ^p   Salmon, Eric ^x,y   Bastin, Christine ^y   Wallin, Anders ^z   Nordlund, Arto ^z   De Mendonça, Alexandre ^aa   Silva, Dina ^aa   Santana, Isabel ^ab   Lemos, Raquel ^ac   Engelborghs, Sebastiaan ^ad,ae   Van Der Mussele, Stefan ^ad   Freund Levi, Yvonne ^af,aj   Wallin, Åsa K ^ag   Hampel, Harald ^ah,ak   Van Der Flier, Wiesje ^ai   Scheltens, Philip ^ai   Visser, Pieter Jelle ^a,ai   more..

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^e UNIVERSITY OF BONN   (Germany)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g UNIVERSITY OF GÖTTINGEN   (Germany)

^h UNIVERSITY OF GENOA   (Italy)

ⁱ UNIVERSITY OF GENOA   (Italy)

^j IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^k UNIVERSITY OF GENEVA   (Switzerland)

^l UNIVERSITY OF COLOGNE   (Germany)

^m AIX MARSEILLE UNIVERSITÉ   (France)

ⁿ VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^o KING'S COLLEGE LONDON   (United Kingdom)

^p KUOPIO UNIVERSITY HOSPITAL   (Finland)

^q MEDICAL UNIVERSITY OF LODZ   (Poland)

^r UNIVERSITY OF PERUGIA   (Italy)

^s ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^t TOULOUSE UNIVERSITY HOSPITAL   (France)

^u UNIVERSITY OF OXFORD   (United Kingdom)

^v Ospedale Briolini   (Italy)

^w UNIVERSITY OF BRESCIA   (Italy)

^x UNIVERSITY OF LIÈGE   (Belgium)

^y UNIVERSITY OF LIÈGE   (Belgium)

^z UNIVERSITY OF GOTHENBURG   (Sweden)

^aa INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^ab CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^ac UNIVERSITY OF COIMBRA   (Portugal)

^ad UNIVERSITY OF ANTWERP   (Belgium)

^ae Hospital Network Antwerp   (Belgium)

^af KAROLINSKA INSTITUTE   (Sweden)

^ag LUND UNIVERSITY   (Sweden)

^ah INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^ai VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^aj KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^ak SORBONNE UNIVERSITÉ   (France)

more..

Author keywords

Alzheimer's disease; Biomarkers; Diagnostic criteria; MCI; Prognosis

Indexed keywords

AMYLOID; BIOLOGICAL MARKER;

AGED; ALZHEIMER DISEASE; ARTICLE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NERVE CELL LESION; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; TASK PERFORMANCE; ADULT; COMPLICATION; DISEASE COURSE; METABOLISM; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84929363392     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awv029     Document Type: Article

References (30)

1. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging and Alzheimer's Association workgroup. Alzheimers Dement 2011; 7: 270-79.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington, DC: American Psychiatric Association; 1994.
3. Baldeiras I, Santana I, Proença MT, Garrucho MH, Pascoal R, Rodrigues A, et al. Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease. J Alzheimers Dis 2008; 15: 117-28.
4. Bastin C, Kerrouche N, Lekeu F, Adam S, Guillaume B, Lemaire C, et al. Controlled memory processes in questionable Alzheimer's disease: A view from neuroimaging research. J Alzheimers Dis 2010; 20: 547-60.
5. Bouwman FH, Verwey NA, Klein M, Kok A, Blankenstein MA, Sluimer JD, et al. New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population. Dement Geriatr Cogn Disord 2010; 30: 1-7.
6. Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 734-46.
7. Dubois B, Feldman HH, Jacova C, Cummings J, DeKosky ST, Barberger-Gateau P, et al. Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurol 2010; 9: 1118-27.
8. Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnositic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet Neurol 2014; 13: 614-29.
9. Eckerström C, Andreasson U, Olsson E, Rolstad S, Blennow K, Zetterberg H, et al. Combination of hippocampal volume and cerebrospinal fluid biomarkers improves predictive value in mild cognitive impairment. Dement Geriatr Cogn Disord 2010; 29: 294-300.
10. Frisoni GB, Prestia A, Zanetti O, Galluzzi S, Romano M, Cotelli M, et al. Markers of Alzheimer's disease in a population attending a memory clinic. Alzheimers Dement 2009; 5: 307-17.
11. Jack CR Jr, Knopman DS, Weigand SD, Wiste HJ, Vemuri P, Lowe V, et al. An operational approach to National Institute on Aging-Alzheimer's association criteria for preclinical Alzheimer disease. Ann Neurol 2012; 71: 765-75.
12. Kornhuber J, Schmidtke K, Froelich L, Perneczky R, Wolf S, Hampel H, et al. Early and differential diagnosis of dementia and mild cognitive impairment. Design and cohort baseline characteristics of the German Dementia Competence Network. Dement Geriatr Cogn Disord 2009; 27: 404-17.
13. Lovestone S, Francis P, Kloszewska I, Meccoci P, Simmons A, Soininen H, et al. AddNeuroMed-the European collaboration for the discovery of novel biomarkers for Alzheimer's disease. Ann NY Acad Sci 2009; 1180: 36-46.
14. Maroco J, Silva D, Rodrigues A, Guerreiro M, Santana I, de Mendonça A. Data mining methods in the prediction of Dementia: A real-data comparison of the accuracy, sensitivity and specificity of Linear Discriminant Analysis, Logistic Regression, Neural Networks, Support Vector Machines, Classification Trees and Random Forests. BMC Res Notes 2011; 4: 299.
15. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-44.
16. Morbelli S, Drzezga A, Perneczky R, Frisoni GB, Caroli A, van Berckel BN, et al. Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project. Neurobiol Aging 2012; 33: 2533-50.
17. Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, et al. Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement 2005; 1: 55-66.
18. Oksengard AR, Cavallin L, Axelsson R, Andersson C, Nágga K, Winblad B, et al. Lack of accuracy for the proposed 'Dubois criteria' in Alzheimer's disease: A validation study from the Swedish brain power initiative. Dement Geriatr Cogn Disord 2010; 30: 374-80.
19. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 183-94.
20. Petersen RC, Aisen P, Boeve BF, Geda YE, Ivnik RJ, Knopman DS, et al. Criteria for mild cognitive impairment due to alzheimer's disease in the community. Ann Neurol 2013; 47: 199-208.
21. Prestia A, Caroli A, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, et al. Prediction of dementia in mild cognitive impairment patients based on core diagnostic markers for Alzheimer disease. Neurology 2013; 80: 1048-56.
22. Scott JM, Bartlett JW, Fox NC, Barnes J. Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Abeta1-42. Ann Neurol 2010; 68: 825-34.
23. SeppäläTT, Koivisto AM, Hartikainen P, Helisalmi S, Soininen H, Herukka SK. Longitudinal changes of CSF biomarkers in Alzheimer's disease. J Alzheimers Dis 2011; 25: 583-94.
24. van der Flier WM, Pijnenburg YA, Prins N, Lemstra AW, Bouwman FH, Teunissen CE, et al. Optimizing Patient Care and Research: the Amsterdam Dementia Cohort. J Alzheimers Dis 2014; 41: 313-27.
25. Van der Mussele S, Marién P, Saerens J, Somers N, Goeman J, De Deyn PP, et al. Behavioral syndromes in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 2014; 38: 319-29.
26. van Rossum IA, Vos SJ, Burns MP, Knol DL, Scheltens P, Soininen H, et al. Injury markers predict cognitive decline in subjects with mild cognitive impairment and amyloid pathology. Neurology 2012; 79: 1809-16.
27. Visser PJ, Verhey FR, Boada M, Bullock R, De Deyn PP, Frisoni GB, et al. Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study. Neuroepidemiology 2008; 30: 254-65.
28. Visser PJ, Vos SJB, van Rossum I, Scheltens P. Comparison of international working Group criteria and national institute on Aging-Alzheimer's association criteria for Alzheimer's disease. Alzheimers Dement 2012; 8: 560-3.
29. Vos SJ, Chengjie X, Visser PJ, Jasielec MS, Hassenstab J, Grant EA, et al. Preclinical Alzheimer's disease and its outcome: A longitudinal cohort study. Lancet Neurol 2013; 12: 957-65.
30. Vos SJ, van Rossum IA, Verhey F, Knol DL, Soininen H, Wahlund LO, et al. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic mild cognitive impairment. Neurology 2013; 80: 1124-32.